Stada to Support Takeover Bid by Bain Capital and Cinven

No Comments
If completed, the deal would value the German company at more than $4.3 billion and represent the latest big deal for a generic drug maker.
By CHAD BRAY from NYT
Business Day
Next PostNewer Post Previous PostOlder Post Home

0 comments

Post a Comment